Article info

Download PDFPDF

SAT0269 The effect of biologic disease-modifying antirheumatic drugs in targeting disease remission in axial spondyloarthritis (AXSPA): a systematic literature review
Free

Authors

  • A.R. Cruz-Machado Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, CHLN, Lisbon Academic Medical CentreRheumatology Research Unit, Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon PubMed articlesGoogle scholar articles
  • S.R. Manica Rheumatology Department, Hospital Egas Moniz, Centro Hospitalar de Lisboa OcidentalCEDOC, NOVA Medical School, Lisbon PubMed articlesGoogle scholar articles
  • J.L. Silva Rheumatology Department, Unidade Local de Saúde do Alto Minho, Ponte de Lima, Portugal PubMed articlesGoogle scholar articles
  • F.M. Pimentel-Santos Rheumatology Department, Hospital Egas Moniz, Centro Hospitalar de Lisboa OcidentalCEDOC, NOVA Medical School, Lisbon PubMed articlesGoogle scholar articles
  • J. Tavares-Costa Rheumatology Department, Unidade Local de Saúde do Alto Minho, Ponte de Lima, Portugal PubMed articlesGoogle scholar articles
  • E. Vieira-Sousa Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, CHLN, Lisbon Academic Medical CentreRheumatology Research Unit, Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon PubMed articlesGoogle scholar articles

Citation

Cruz-Machado A, Manica S, Silva J, et al
SAT0269 The effect of biologic disease-modifying antirheumatic drugs in targeting disease remission in axial spondyloarthritis (AXSPA): a systematic literature review

Publication history

  • First published June 12, 2018.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.